Track the Clover Biopharmaceuticals, Ltd. - B stock price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares are listed on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Clover Biopharmaceuticals, Ltd. - B has recorded 35 reports. Market capitalisation: €2.1bn. The latest transaction was reported on 21 July 2026 (Sale). Among the most active insiders: Liang Peng. Every trade is openly available.
35
Insider Decl.
n/a
Thresholds
n/a
11 ops.
Buy Volume
€622,892
14 ops.
Sell Volume
19Σ signal
Buys n/a€622,892 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Clover Biopharmaceuticals, Ltd. is a biopharmaceutical company focused on developing vaccines and therapies for infectious diseases. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.